HFE genotypes, haemochromatosis diagnosis and clinical outcomes to age 80: a prospective cohort study in UK Biobank

Mitchell R Lucas, Janice L Atkins, Luke C Pilling, Jeremy Shearman, David Melzer
doi: https://doi.org/10.1101/2023.11.17.23298637

Article Information

doi 
https://doi.org/10.1101/2023.11.17.23298637
History 
  • February 13, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Mitchell R Lucas1,*,
  2. Janice L Atkins1,*,
  3. Luke C Pilling1,
  4. Jeremy Shearman2 and
  5. David Melzer1,**
  1. 1Epidemiology and Public Health Group, Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, UK
  2. 2Department of Gastroenterology, South Warwickshire University NHS Foundation Trust, UK
  1. ↵**Corresponding author
    : David Melzer, Professor of Epidemiology and Public Health, The Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, St Luke’s Campus, College House, Magdalen Road, Exeter, Devon, EX1 2LU, UK. E-mail: d.melzer{at}exeter.ac.uk

  1. ↵* Contributed equally to this study

Back to top
Posted February 13, 2024.
Download PDF

Supplementary Material

Data/Code
Email
HFE genotypes, haemochromatosis diagnosis and clinical outcomes to age 80: a prospective cohort study in UK Biobank
Mitchell R Lucas, Janice L Atkins, Luke C Pilling, Jeremy Shearman, David Melzer
medRxiv 2023.11.17.23298637; doi: https://doi.org/10.1101/2023.11.17.23298637
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area